Mirosława Kijko-Nowak, Małgorzata Marchelek-Myśliwiec, Tomasz Nowak, Violetta Dziedziejko

Oral anticoagulants in chronic kidney disease
2018-11-30

DOI: 10.32383/farmpol/118634

Chronic kidney disease (CKD) is a disease with heterogeneous etiology. Kidney failure results in a decrease of glomerular filtration, which requires reducing the dose of many drugs. Cardiovascular complications are the most common cause of death in this group of patients. Since new oral anticoagulants (NOACs) have been available for use, the question is whether these drugs can be safely used in CKD patients.

Keywords: anticoagulants, vitamin K antagonists, new oral anticoagulants, chronic kidney disease.

© Farm Pol, 2018, 74(11): 641-644